BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1359114)

  • 1. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
    Szabo S; Reichlin S; Bollinger-Gruber JA; Brown A
    J Pharmacol Exp Ther; 1992 Nov; 263(2):752-6. PubMed ID: 1359114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin depletion by cysteamine: mechanism and implication for duodenal ulceration.
    Szabo S; Reichlin S
    Fed Proc; 1985 Jun; 44(9):2540-5. PubMed ID: 2860015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantethine, a cysteamine precursor, depletes immunoreactive somatostatin and prolactin in the rat.
    Reichlin S; Bollinger-Gruber JA
    Endocrinology; 1985 Aug; 117(2):492-5. PubMed ID: 2862009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin in rat tissues is depleted by cysteamine administration.
    Szabo S; Reichlin S
    Endocrinology; 1981 Dec; 109(6):2255-7. PubMed ID: 6118261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach.
    McIntosh C; Bakich V; Trotter T; Kwok YN; Nishimura E; Pederson R; Brown J
    Gastroenterology; 1984 May; 86(5 Pt 1):834-8. PubMed ID: 6142843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine-induced depletion of somatostatin and prolactin.
    Millard WJ; Sagar SM; Martin JB
    Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosal protection by somatostatins.
    Kusterer K; Rohr G; Schwedes U; Usadel KH; Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():97-9. PubMed ID: 2882058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relations between alkyl nucleophilic chemicals causing duodenal ulcer and adrenocortical necrosis.
    Szabo S; Reynolds ES; Unger SH
    J Pharmacol Exp Ther; 1982 Oct; 223(1):68-76. PubMed ID: 7120129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the duodenal ulcerogen cysteamine on somatostatin and gastrin cells in the rat.
    Seiler M; Szabo S; Ourieff S; McComb DJ; Kovacs K; Reichlin S
    Exp Mol Pathol; 1983 Oct; 39(2):207-18. PubMed ID: 6137403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.
    Jacobs LS; Lorenson MY
    Endocrinology; 1984 Sep; 115(3):1210-7. PubMed ID: 6430683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sulfhydryls and early vascular lesions in gastric mucosal injury.
    Szabó S
    Acta Physiol Hung; 1984; 64(3-4):203-14. PubMed ID: 6532115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteamine-induced decrease of somatostatin in rat brain synaptosomes in vitro.
    Widmann R; Sperk G
    Endocrinology; 1987 Oct; 121(4):1383-9. PubMed ID: 2888645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
    Olson RD; MacDonald JS; vanBoxtel CJ; Boerth RC; Harbison RD; Slonim AE; Freeman RW; Oates JA
    J Pharmacol Exp Ther; 1980 Nov; 215(2):450-4. PubMed ID: 7441509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
    Fukuhara S; Suzuki H; Masaoka T; Arakawa M; Hosoda H; Minegishi Y; Kangawa K; Ishii H; Kitajima M; Hibi T
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G138-45. PubMed ID: 15778430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of somatostatin-14 and gastrin I binding sites in rat gastrointestinal mucosa by ulcerogenic dose of cysteamine.
    Rossowski WJ; Ozden A; Ertan A; Arimura A
    Life Sci; 1987 May; 40(18):1783-9. PubMed ID: 2883547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine, the most potent ulcerogenic drug known so far, powerfully activates carbonic anhydrase I, II and IV. In vitro and in vivo studies.
    Puscas I; Coltau M; Maghiar A; Domuta G
    Exp Toxicol Pathol; 2000 Oct; 52(5):431-5. PubMed ID: 11089894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local injection of cysteamine and cystamine on somatostatin and neuropeptide Y levels in the rat striatum.
    Widmann R; Maas D; Sperk G
    J Neurochem; 1988 Jun; 50(6):1682-6. PubMed ID: 2897423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of somatostatin binding sites in cytosol of rabbit gastric fundic mucosa by cysteamine administration.
    Gonzalez-Guijarro L; López-Ruiz MP; Prieto JC; Arilla E
    Gen Pharmacol; 1986; 17(6):637-9. PubMed ID: 3028901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.